compounded semaglutide lawsuit Novo Nordisk CEO Maziar Mike Doustdar says it’s suing Hims & Hers for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill. Read more Tong settles with 'bootleg' GLP-1

In addition, in October 2024, AstraZeneca announced that it will discontinue marketing brand Byetta

Many pharmacies sell small medical travel cases designed for this exact purpose

Design & Development by Goldman Marketing Group | Sitemap | Privacy Policy | Official Practice Information | If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact us at 858.943.2113.

BMI 30 or higher strong chance of coverage BMI 27+ with a weight-related condition may qualify with a supporting diagnosis Employer plan rules coverage limits and approved medications vary Prior authorization required WeightWatchers helps you navigate the paperwork Insurance can bring your monthly medication cost down to as little as $0$100/month